Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
For emerging markets worldwide, the average value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health and pharmaceuticals sector as of 2023 was a multiple of approximately 19.9x. Companies operating in the healthcare information & technology industry saw the highest valuation multiple with EV/EBITDA valued at 36.5x.
Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Brand value
Global overview
5
- Premium Statistic Aggregate value of most valuable brands worldwide 2006-2023
- Basic Statistic Most valuable brands worldwide 2024
- Premium Statistic Fastest growing brands worldwide 2023, by brand value growth
- Basic Statistic Most valuable nation brands 2024
- Basic Statistic Biggest companies in the world by market value 2023
Regional overview
6
- Premium Statistic Value of most valuable brands worldwide 2023, by region
- Premium Statistic Most valuable brands worldwide 2024, by region
- Basic Statistic Most valuable European brands 2023
- Premium Statistic Most valuable brands in Latin America 2023
- Basic Statistic Most valuable brands APAC 2023, by brand value
- Premium Statistic Brand value of the leading 10 most valuable Middle Eastern brands 2023
Leading countries
8
- Premium Statistic Distribution of brand value worldwide 2023, by country
- Basic Statistic Most valuable U.S. brands 2024
- Basic Statistic Most valuable French brands 2023
- Basic Statistic Most valuable German brands 2023
- Basic Statistic Most valuable brands of China by BrandZ 2023
- Basic Statistic Most valuable brands in India 2023
- Premium Statistic Most valuable brands in Brazil 2023-2024
- Premium Statistic Most valuable Mexican brands 2023
Industry leaders
8
- Premium Statistic Brand value worldwide 2023, by industry
- Premium Statistic Most valuable brands worldwide 2023, by industry
- Basic Statistic Brand value growth 2023, by sector
- Basic Statistic Most valuable technology brands worldwide 2023
- Premium Statistic Telecom operators by brand value 2024
- Premium Statistic Brand value of the leading FMCG brands worldwide 2023
- Premium Statistic World: most valuable retail brands 2023
- Premium Statistic Most valuable media & entertainment brands worldwide 2023
Further related statistics
10
- Financial advisors ranked by M&A transactions in the UK 2022, by deal value
- Hugo Boss - EBITDA 2005-2023
- Net earnings of UnitedHealth Group 2007-2023
- Leading financial advisors to M&A deals in the UK 2022, by deal volume
- Overweight prevalence in England 2000-2021, by gender
- Medicaid long-term care services expenditures by type of service 1990-21
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
- Deaths by prostate cancer in the U.S. 1950-2019
Further Content: You might find this interesting as well
Statistics
- Financial advisors ranked by M&A transactions in the UK 2022, by deal value
- Hugo Boss - EBITDA 2005-2023
- Net earnings of UnitedHealth Group 2007-2023
- Leading financial advisors to M&A deals in the UK 2022, by deal volume
- Overweight prevalence in England 2000-2021, by gender
- Medicaid long-term care services expenditures by type of service 1990-21
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
- Deaths by prostate cancer in the U.S. 1950-2019
Topics
Health careLeonard N. Stern School of Business. (January 5, 2023). Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry [Graph]. In Statista. Retrieved June 12, 2024, from https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/
Leonard N. Stern School of Business. "Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry." Chart. January 5, 2023. Statista. Accessed June 12, 2024. https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/
Leonard N. Stern School of Business. (2023). Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry. Statista. Statista Inc.. Accessed: June 12, 2024. https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/
Leonard N. Stern School of Business. "Average Ev/Ebitda Multiples in The Health and Pharmaceuticals Sector in Emerging Markets Worldwide from 2019 to 2023, by Industry." Statista, Statista Inc., 5 Jan 2023, https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/
Leonard N. Stern School of Business, Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry Statista, https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/ (last visited June 12, 2024)
Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry [Graph], Leonard N. Stern School of Business, January 5, 2023. [Online]. Available: https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/